{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:09:58Z","timestamp":1782781798718,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10875-022-01404-4","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T03:02:37Z","timestamp":1670814157000},"page":"647-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome"],"prefix":"10.1007","volume":"43","author":[{"given":"Salam","family":"Abbara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3572-8985","authenticated-orcid":false,"given":"J\u00e9r\u00e9mie F.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Leclerc-Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Schlatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cisternino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Rouzaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Elisabeth","family":"Bougnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail S.","family":"Lionakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8325-8060","authenticated-orcid":false,"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"issue":"4","key":"1404_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","volume":"91","author":"MO Chandesris","year":"2012","unstructured":"Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE Syndrome: molecular, cellular, and clinical features from a French National Survey. Medicine (Baltimore). 2012;91(4):e1-19.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"1404_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cmi.2016.05.016","volume":"22","author":"B Pilmis","year":"2016","unstructured":"Pilmis B, Puel A, Lortholary O, Lanternier F. New clinical phenotypes of fungal infections in special hosts. Clin Microbiol Infect. 2016;22(8):681\u20137.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1404_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12016-009-8134-1","volume":"38","author":"J Heimall","year":"2010","unstructured":"Heimall J, Freeman A, Holland SM. Pathogenesis of hyper IgE syndrome. Clin Rev Allergy Immunol. 2010;38(1):32\u20138.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1404_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fimmu.2020.00038","volume":"11","author":"F Danion","year":"2020","unstructured":"Danion F, Aimanianda V, Bayry J, Dur\u00e9ault A, Wong SSW, Bougnoux ME, et al. Aspergillus fumigatus infection in humans with STAT3-deficiency is associated with defective interferon-gamma and Th17 responses. Front Immunol. 2020;11:38.","journal-title":"Front Immunol"},{"issue":"6","key":"1404_CR5","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.jaip.2019.02.041","volume":"7","author":"A Dur\u00e9ault","year":"2019","unstructured":"Dur\u00e9ault A, Tcherakian C, Poiree S, Catherinot E, Danion F, Jouvion G, et al. Spectrum of pulmonary aspergillosis in hyper-IgE syndrome with autosomal-dominant STAT3 deficiency. J Allergy Clin Immunol Pract. 2019;7(6):1986-1995.e3.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1404_CR6","doi-asserted-by":"crossref","unstructured":"Odio CD, Milligan KL, McGowan K, Rudman Spergel AK, Bishop R, Boris L et al. Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome. J Allergy Clin Immunol. 2015;136(5):1411\u20131413.e1\u20132","DOI":"10.1016\/j.jaci.2015.07.003"},{"issue":"4","key":"1404_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00014-07","volume":"20","author":"M Nucci","year":"2007","unstructured":"Nucci M, Anaissie E. Fusarium Infections in immunocompromised patients. Clin Microbiol Rev. 2007;20(4):695\u2013704.","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"1404_CR8","doi-asserted-by":"publisher","first-page":"1105.e1","DOI":"10.1016\/j.cmi.2018.05.006","volume":"24","author":"F Nucci","year":"2018","unstructured":"Nucci F, Nou\u00e9r SA, Capone D, Nucci M. Invasive mould disease in haematologic patients: comparison between fusariosis and aspergillosis. Clin Microbiol Infect. 2018;24(10):1105.e1-1105.e4.","journal-title":"Clin Microbiol Infect"},{"issue":"02","key":"1404_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1055\/s-2004-824900","volume":"25","author":"M Lionakis","year":"2004","unstructured":"Lionakis M, Kontoyiannis D. Fusarium infections in critically ill patients. Semin Respir Crit Care Med. 2004;25(02):159\u201369.","journal-title":"Semin Respir Crit Care Med"},{"key":"1404_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/1469-0691.12465","volume":"20","author":"AM Tortorano","year":"2014","unstructured":"Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect. 2014;20:27\u201346.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"1404_CR11","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/jac\/dkaa516","volume":"76","author":"M Nucci","year":"2021","unstructured":"Nucci M, Jenks J, Thompson GR, Hoenigl M, dos Santos MC, Forghieri F, et al. Do high MICs predict the outcome in invasive fusariosis? J Antimicrob Chemother. 2021;76(4):1063\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1404_CR12","doi-asserted-by":"publisher","first-page":"106083","DOI":"10.1016\/j.ijantimicag.2020.106083","volume":"56","author":"C Bouchand","year":"2020","unstructured":"Bouchand C, Nguyen D, Secretan PH, Vidal F, Guery R, Auvity S, et al. Voriconazole topical cream formulation: evidence for stability and antifungal activity. Int J Antimicrob Agents. 2020;56(3):106083.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"1404_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","volume":"122","author":"ED Renner","year":"2008","unstructured":"Renner ED, Rylaarsdam S, A\u0148over-Sombke S, Rack AL, Reichenbach J, Carey JC, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol. 2008;122(1):181\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1404_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2007.05.016","volume":"50","author":"S Sano","year":"2008","unstructured":"Sano S, Chan KS, DiGiovanni J. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci. 2008;50(1):1\u201314.","journal-title":"J Dermatol Sci"},{"issue":"3","key":"1404_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000351912","volume":"6","author":"SP Smeekens","year":"2014","unstructured":"Smeekens SP, Huttenhower C, Riza A, van de Veerdonk FL, Zeeuwen PLJM, Schalkwijk J, et al. Skin Microbiome imbalance in patients with STAT1\/STAT3 Defects impairs innate host defense responses. J Innate Immun. 2014;6(3):253\u201362.","journal-title":"J Innate Immun"},{"issue":"10","key":"1404_CR16","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1128\/AAC.00286-10","volume":"54","author":"O Lortholary","year":"2010","unstructured":"Lortholary O, Obenga G, Biswas P, Caillot D, Chachaty E, Bienvenu AL, et al. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother. 2010;54(10):4446\u201350.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1404_CR17","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1542\/peds.2005-2213","volume":"118","author":"KC Klein","year":"2006","unstructured":"Klein KC, Blackwood RA. Topical Voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant. Pediatrics. 2006;118(2):e506\u20138.","journal-title":"Pediatrics"},{"issue":"3","key":"1404_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s11552-009-9252-1","volume":"5","author":"JW Pyle","year":"2010","unstructured":"Pyle JW, Holladay J, Molnar JA, Martin JS, DeFranzo AJ. Multiple modality treatment regimen in an aggressive resistant fungal hand infection: a case report. HAND. 2010;5(3):318\u201321.","journal-title":"HAND"},{"key":"1404_CR19","doi-asserted-by":"crossref","unstructured":"Matthew D B, Lisa I, Jake E T. Multimodal Therapy for recalcitrant cutaneous fusarium solani infection in a patient with hyper-IgE syndrome. Dermatol Arch [Internet]. 2017 Jul 3 [cited 2020 Feb 28];1(2). Available from: https:\/\/scholars.direct\/Articles\/dermatology\/dma-1-009.php?jid=dermatology","DOI":"10.36959\/661\/295"},{"issue":"2","key":"1404_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/1346-8138.15168","volume":"47","author":"M Shi","year":"2020","unstructured":"Shi M, Lu S, Li J, Cai W, Zhang J, Ma J, et al. Cutaneous fusariosis caused by Fusarium lichenicola in a child with hyper-immunoglobulin E syndrome. J Dermatol. 2020;47(2):181\u20134.","journal-title":"J Dermatol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01404-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01404-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01404-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T08:24:54Z","timestamp":1677227094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01404-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01404-4","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"1 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of their case report and of images in Figs.  and .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}